Company insider · SEC Form 4
Martine Rothblatt
United Therapeutics Corporation (UTHR)
SEC Form 4 data · Jul 01, 2024 – Jun 30, 2026
Martine Rothblatt's stock sales and purchases
Every open-market purchase and sale Martine Rothblatt reported on Form 4 over two years, as SEC lists the filer: “Rothblatt Martine A”. Grants, option exercises and gifts are not trades and are left out.
- Bought
- —
- Sold
- $616.1M
- Trades
- 1,424
- Sales on a 10b5-1 plan
- 100%
UTHRUnited Therapeutics CorporationChairperson & CEO
1,424 sales worth $616.1M (1419 on a 10b5-1 plan). Largest sale: $2.5M on May 22, 2026.
| Quarter | Bought | Sold |
|---|---|---|
| Q2 2026 | — | −$326.7M655 sales · all on a plan |
| Q1 2026 | — | −$110.6M287 sales · all on a plan |
| Q4 2025 | — | −$104.5M174 sales · all on a plan |
| Q3 2025 | — | −$28M34 sales · 29 on a plan |
| Q3 2024 | — | −$46.3M274 sales · all on a plan |
Most recent trades30 of 1,424
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$1.2M
Jun 29, 2026
2,165 sh · $545.30
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$933.2K
Jun 29, 2026
1,702 sh · $548.29
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$931.4K
Jun 29, 2026
1,705 sh · $546.28
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$867.8K
Jun 29, 2026
1,594 sh · $544.40
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$415.3K
Jun 29, 2026
759 sh · $547.12
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$317.9K
Jun 29, 2026
585 sh · $543.37
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$236.1K
Jun 29, 2026
430 sh · $548.96
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$194.8K
Jun 29, 2026
360 sh · $541.24
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$64.8K
Jun 29, 2026
120 sh · $539.98
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$43.3K
Jun 29, 2026
80 sh · $541.86
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$1.2M
Jun 26, 2026
2,128 sh · $541.24
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$549.8K
Jun 26, 2026
1,012 sh · $543.32
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$549.6K
Jun 26, 2026
1,018 sh · $539.89
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$532.9K
Jun 26, 2026
983 sh · $542.14
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$478.6K
Jun 26, 2026
872 sh · $548.90
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$344.5K
Jun 26, 2026
640 sh · $538.34
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$305.5K
Jun 26, 2026
560 sh · $545.52
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$285.8K
Jun 26, 2026
520 sh · $549.69
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$247.8K
Jun 26, 2026
452 sh · $548.13
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$238.9K
Jun 26, 2026
439 sh · $544.18
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$220.3K
Jun 26, 2026
400 sh · $550.79
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$154.7K
Jun 26, 2026
280 sh · $552.36
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$85.3K
Jun 26, 2026
156 sh · $547.00
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$22.1K
Jun 26, 2026
40 sh · $553.49
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$1M
Jun 25, 2026
1,814 sh · $551.61
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$982.7K
Jun 25, 2026
1,778 sh · $552.68
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$890.7K
Jun 25, 2026
1,617 sh · $550.86
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$443.2K
Jun 25, 2026
800 sh · $553.97
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$418.8K
Jun 25, 2026
762 sh · $549.55
Martine Rothblatt10b5-1
Chairperson & CEO · Director
−$371.8K
Jun 25, 2026
684 sh · $543.54
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 2,165 | $545.30 | −$1.2M |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,702 | $548.29 | −$933.2K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,705 | $546.28 | −$931.4K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,594 | $544.40 | −$867.8K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 759 | $547.12 | −$415.3K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 585 | $543.37 | −$317.9K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 430 | $548.96 | −$236.1K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 360 | $541.24 | −$194.8K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 120 | $539.98 | −$64.8K |
| Jun 29, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 80 | $541.86 | −$43.3K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 2,128 | $541.24 | −$1.2M |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,012 | $543.32 | −$549.8K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,018 | $539.89 | −$549.6K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 983 | $542.14 | −$532.9K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 872 | $548.90 | −$478.6K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 640 | $538.34 | −$344.5K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 560 | $545.52 | −$305.5K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 520 | $549.69 | −$285.8K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 452 | $548.13 | −$247.8K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 439 | $544.18 | −$238.9K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 400 | $550.79 | −$220.3K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 280 | $552.36 | −$154.7K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 156 | $547.00 | −$85.3K |
| Jun 26, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 40 | $553.49 | −$22.1K |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,814 | $551.61 | −$1M |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,778 | $552.68 | −$982.7K |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 1,617 | $550.86 | −$890.7K |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 800 | $553.97 | −$443.2K |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 762 | $549.55 | −$418.8K |
| Jun 25, 2026 | Martine Rothblatt10b5-1Chairperson & CEO · Director | 684 | $543.54 | −$371.8K |
From SEC's quarterly Form 3, 4 and 5 data sets through Jun 30, 2026; newer filings appear on each company's page and the live dashboard. A 10b5-1 plan fixes a sale's dates or amounts in advance. Monitoring, not advice.
Track Martine Rothblatt live — and everyone else
The dashboard reads every new filing within minutes: every Form 4 the moment it clears EDGAR, this person's included — plus live insider buying across the whole market, the most-bought board, and performance versus the S&P. Free to start.
Questions
- How much UTHR stock has Martine Rothblatt sold?
- Between Jul 01, 2024 and Jun 30, 2026, Martine Rothblatt sold $616.1M of United Therapeutics Corporation (UTHR) stock in 1,424 open-market sales, 1419 of them under a pre-arranged Rule 10b5-1 trading plan. The largest single sale was $2.5M on May 22, 2026.
- Has Martine Rothblatt bought UTHR stock?
- No open-market purchase of UTHR by Martine Rothblatt appears in SEC's Form 4 data for trades between Jul 01, 2024 and Jun 30, 2026. Share grants and option exercises are not counted as purchases.
- Are Martine Rothblatt's stock sales planned in advance?
- 100% of the sales on record (1419 of 1424) were marked on the Form 4 as made under a Rule 10b5-1 plan, which fixes dates or amounts months ahead so the sale is not a reaction to that day's news. A planned sale says nothing about where the stock is going.
- Where does this data come from?
- From SEC's quarterly Form 3, 4 and 5 data sets. Company insiders like Martine Rothblatt — SEC lists the filer as "Rothblatt Martine A", role Chairperson & CEO — must report a trade in their company's stock within two business days. Only open-market purchases (code P) and sales (code S) are counted; grants, option exercises and gifts are not.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.